drug-pricing
6 stories related to this topic, newest first.
Mike Burdett from CROMER, UK / Wikimedia (CC BY-SA 2.0)Dozens of MPs Oppose Health Secretary's New NHS Drug Payment Powers
Dozens of MPs have expressed opposition to a health secretary's decision to gain authority over NHS drug pricing. The move involves overriding an institute's judgments on cost-effectiveness amid concerns about legality and potential benefits to pharmaceutical companies. Critics i…
marketwatch.comRegeneron Agrees to Lower Drug Prices and Offer Free Gene Therapy in U.S. Deal
Biotech company Regeneron has entered into an agreement with the U.S. government to reduce medication costs for American patients. The deal includes offering a new hearing-loss gene therapy at no charge to eligible individuals. This is part of broader efforts to align U.S. drug p…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)China's State Council Issues Guidelines on Innovative Drug Pricing
China's State Council has released new guidelines aimed at supporting innovative drug pricing through value-based methods while reducing generic drug prices via market competition. A Citigroup analyst described the guidelines as the most significant in a decade.
medpagetoday.comFDA to Review Compounding Pharmacies’ Peptide Manufacturing; Alzheimer’s Drug Benefits Under Review
The FDA will hold an advisory panel meeting to consider allowing compounding pharmacies to produce certain peptides. A recent review of Alzheimer’s drugs found limited clinical benefits, though some experts noted differences among the drugs studied. Additionally, a report indicat…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Maryland Board Establishes $204 Monthly Cap on Jardiance for Public Purchases by 2027
The Maryland Prescription Drug Affordability Board has established an upper payment limit for Jardiance, a type 2 diabetes medicine, capping its price at $204 for a 30-day supply by January 2027. The board will oversee a process to lower costs for state and local governments. The…
The Boston GlobeReader Responses to GLP-1 Weight Loss Drugs and Insurance Coverage Changes
Readers of The Boston Globe have shared varied opinions on GLP-1 medications for obesity treatment following a February 22 article. Some highlight the drugs' benefits for health conditions beyond weight loss, while others question obesity as a disease and oppose insurance subsidi…